2-Bromo-4,4'-di-tert-butyl-1,1'-biphenyl

Catalog No. :
ACNIPG304
CAS No. :
70728-89-1
Molecular Formula :
C20H25Br
Molecular Weight :
345.32

IUPAC Name:2-bromo-4,4'-di-tert-butyl-1,1'-biphenyl

2-Bromo-4,4'-di-tert-butyl-1,1'-biphenyl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g99%$102.00Login to see priceIn stockInquiry
500g99%$379.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-4,4'-di-tert-butyl-1,1'-biphenyl
IUPAC Name2-bromo-4,4'-di-tert-butyl-1,1'-biphenyl
MDL No.MFCD20921696
Molecular FormulaC20H25Br
Molecular Weight345.32
SMILESCC(C)(C)C1=CC=C(C=C1)C1=C(Br)C=C(C=C1)C(C)(C)C
InChI KeyOPPSYCGZHQVDPM-UHFFFAOYSA-N
SynonymCX1319 | 2-Bromo-4,4'-di-tert-butyl-1,1'-biphenyl | CS-0171690 | AKOS016007855 | SCHEMBL1823358 | DTXSID70501857 | MFCD20921696 | BS-22345 | A901056 | 2-Bromo-4-tert-butyl-1-(4-tert- butylphenyl)benzene | 2-BROMO-4-TERT-BUTYL-1-(4-TERT-BUTYLPHENYL)BENZENE
CAS No.70728-89-1
PubChem CID12541264

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACNIPG304 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVXQG973 route compound structure diagram
    ACVXQG9731625-91-8 In Stock
  4. Then
  5. ACNIPG304 route product structure diagram
    ACNIPG30470728-89-1 In Stock
Inquiry

2. ACNIPG304 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVXQG973 route compound structure diagram
    ACVXQG9731625-91-8 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACNIPG304 route product structure diagram
    ACNIPG30470728-89-1 In Stock
Inquiry

Comments (0)